| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |